An epigenetic component of hematopoietic stem cell aging amenable to reprogramming into a young state.
KEY POINTS
1) Hematopoietic stem cell aging associate with stable transcriptional alterations that persist through transplantation.
2) Somatic cell reprogramming of aged hematopoietic stem and progenitor cells reverses functional defects associated with hematopoietic aging.
ABSTRACT
Aging of hematopoietic stem cells (HSCs) leads to several functional changes, including alterations affecting self--renewal and differentiation. While it is well established that many of the age--induced changes are intrinsic to HSCs, less is known about the stability of this state. Here, we entertained the hypothesis that HSC aging is driven by the acquisition of permanent genetic mutations. To examine this issue at a functional level in vivo, we applied induced pluripotent stem (iPS) cell reprogramming of aged hematopoietic progenitors and allowed the resulting aged-derived iPS cells to reform hematopoiesis via blastocyst complementation. Next, we functionally characterized iPS--derived HSCs in primary chimeras and following the transplantation of 're--differentiated' HSCs into new hosts; the gold standard to assess HSC function. Our data demonstrate remarkably similar functional properties of iPS--derived and endogenous blastocyst--derived HSCs, despite the extensive chronological and proliferative age of the former. Our results therefore favor a model in which an underlying, but reversible, epigenetic component is a hallmark of HSC aging rather than being driven by an increased DNA mutation burden.
INTRODUCTION
Many of the pathologies that could benefit from regenerative stem cell based therapies are age--associated 1 . An evident example is represented by bone marrow (BM) transplantation, a therapeutic modality that relies on the regenerative capacity of hematopoietic stem cells (HSCs) and where graft age is one of the most significant negative parameters for successful outcome 2 . One key mechanism proposed to underlie HSC aging involves the acquisition of permanent genetic changes such as accumulation of DNA damage and/or telomere attrition 3 . Yet, while there is a potential role for DNA damage in HSC aging, it is currently unclear if accumulation of DNA damage could explain all or even a part of the distinct transcriptional changes that associate with HSC aging and that ultimately underlie their altered function 4--7 .
For the purpose of regenerative medicine, alterations in the underlying genomic DNA sequence would be problematic to correct efficiently. By contrast, it might be more conceivable to alter the regulation of the transcriptome of a stem cell population, assuming permanent genomic damage does not underlie and dictate the transcriptional changes. One conceptual example is represented by induced pluripotent stem cells (iPS). iPS cells, created by transcription factor--mediated reprogramming of somatic cells 8 , progressively gain particular epigenetic features during the reprogramming process while simultaneously loosing those of the somatic starting cell 9, 10 , to finally reach a relatively stable embryonic stem cell (ES)-like state 11 .
Here, to explore the stability and potential reversibility of hematopoietic progenitor cell aging, we generated iPS cells from aged hematopoietic stem and progenitor cells (HSPCs). Next, we used these iPS cells to complement blastocysts.
IPS--derived HSCs in chimeric mice were evaluated for several parameters normally altered with age, including their telomere length, reconstitution ability, lineage competence and production of naïve T cells. Our data suggest that a dominant feature of chronological HSC aging is an epigenetic "drift", which can be reversed by epigenetic reprogramming.
MATERIALS AND METHODS

Mice
All mice were on a C57BL/6 background with the congenic marker combinations CD45.1, CD45.2 or F1CD45.1 x CD45.2. Animals were housed at animal facilities at Lund University. The Transgenic Core Facility at Lund University performed blastocyst injections. All animal experiments were performed with consent from a local ethical committee.
Retrovirus production
Retroviral vectors (pMXs--Oct3/4--IP, pMXs--Sox2--IP, pMXs--Klf4, pMXs--c--Myc--IP) were acquired from Addgene (Cambridge, MA) and were generously deposited by Shinya Yamanaka. pMX--GFP was obtained from Cell Biolabs (San Diego, CA). Replication incompetent viruses were produced by transfecting the vectors into Plat--E packaging cells (Cell Biolabs, San Diego, CA) using Lipofectamine 2000 (Invitrogen, Carlsbad, CA). Supernatants were harvested 48h post transfection and titered using the Retro--X qRT--PCR Titration Kit (Clontech, France) and FACS (for pMX--GFP). Viruses used in experiments had titers ranging from 4 x 10 6 to 4 x 10 8 viral particles/ml.
Hematopoietic stem and progenitor isolation
For iPS generation, mouse bone marrow was depleted of mature cells using a cocktail of biotinylated antibodies (B220, CD4, CD8a, CD11b, Gr--1, Ly6c, Ter119) together with anti--biotin MACS beads (Miltenyi Biotech, Germany), before being further enriched for hematopoietic stem and progenitor cells (HSPCs) by magnetic enrichment of CD117 positive cells (Miltenyi Biotech, Germany). For HSPCs isolation and analysis, lineage--depleted samples were stained with Streptavidin conjugated to QD605 (Invitrogen, Carlsbad, CA) and antibodies recognizing c--Kit, Sca--1, CD48, CD105, CD150, CD45.1 and CD45.2, and sorted on a FACS Aria. Propidium iodide (Invitrogen, Carlsbad, CA) was used to exclude dead cells.
iPS generation from hematopoietic stem and progenitor cells
For prestimulation of primary cells prior to and during transduction, cells were cultured in OptiMEM (Invitrogen, Carlsbad, CA) supplemented with 10% Fetal Calf Serum (FCS), Penicillin/Streptomycin (Invitrogen, Carlsbad, CA), 50 ng/ml SCF, 5 ng/ml IL3 (Peprotech Inc.) and 5 U/ml EPO (Janssen--Cilag, Bersee, Belgium). Both candidate and established iPS cells were cultured under standard ES cell conditions; grown on irradiated mouse embryonic fibroblasts in DMEM (Invitrogen, Carlsbad, CA) containing 15% FCS, Penicillin/Streptomycin (Invitrogen, Carlsbad, CA), 1 mM Sodium pyruvate (Invitrogen, Carlsbad, CA), 0.1 mM β--mercaptoethanol (Invitrogen, Carlsbad, CA), 1x MEM NEAA (Invitrogen, Carlsbad, CA) and 10 3 U/ml LIF (Millipore, Billerica, MA).
To generate iPS lines, 50,000 Lin -c--Kit + cells were transduced for 2 days using Retronectin (Takara Bio Inc., France) coated plates preincubated with retroviruses and thereafter transferred to ES cell culture conditions. The cells were cultured for 14 days with daily media changes. On day 14, 25 candidate iPS cells were sorted into individual wells of a 96--well plate in ES cell culture conditions based on their negativity for GFP, as iPS induction coincides with efficient silencing of retroviral long terminal repeat regions 8 and CD45, a pan--hematopoietic marker lost during iPS conversion, and by being SSEA--1 and Epcam positive.
Characterization of iPS clones.
iPS lines were assayed for viral vector integration by PCR using one primer specific for each vector's coding sequence and a common primer directed against the vector backbones. Chimeric mice were genotyped with a similar strategy. PCR reactions were run using Taq polymerase (Takara Bio Inc., France) with initial incubation at 94°C for 2min followed by 35 cycles of 30 sec at 94°C, 30 sec at 60°C and 30 sec at 72°C. In vitro differentiation capacity was investigated by embryoid body formation by cultivating 250 ES or iPS cells in 20ul hanging droplets for 48h in IMDM (Invitrogen, Carlsbad, CA) supplemented with 20% FCS, Penicillin/Streptomycin (Invitrogen, Carlsbad, CA), 1 mM Sodium pyruvate (Invitrogen, Carlsbad, CA), 0.1 mM β--mercaptoethanol (Invitrogen, Carlsbad, CA) and GlutaMAX (Invitrogen, Carlsbad, CA). Thereafter, cells were pooled and cultured in petri dishes for 12--14 days before analysis. To verify iPS chimerism in adult mice, hippocampal brain sections were used to detect Y chromosome (from iPS cells) by starFISH fluorescence In Situ hybridization protocol (Cambio Ltd, Cambridge, UK). 
Bone marrow transfer and peripheral blood analysis
Measurement of T cell excision circles
T cell receptor excision circles (TRECs) were measured in sorted CD4+/CD8+ splenic T cells by adapting a previously described protocol 13 . Briefly, the sorted cells were lysed using Proteinase K (Roche, Mannheim, Germany) and assayed for relative TREC content using a SYBR green--based qPCR approach where the cycle threshold value of a primer pair directed against a TREC was normalized against that of the single--copy gene Myt--1. To measure the naïve T cell competence of HSCs in BM transfer experiments, the chimerism of the splenic CD4+/CD8+ compartment was divided by the actual, or estimated, number of transplanted HSCs and multiplied by the relative TREC incidence acquired by qPCR.
Telomere length measurement
To estimate telomere lengths in individual cells, single--cells were isolated using FACS and assayed as previously described 14--16 .
Affymetrix gene expression analysis
RNA was extracted from 10,000 sorted HSCs (Lin --Sca1 + c--Kit + CD48 --CD150 + ) isolated from young or aged mice, or from recipients of young and old bone marrow cells, where they in addition were selected for appropriate CD45 isoform expression, using the RNeasy--micro mRNA purification kit (QIAGEN, Hilden, Germany) as previously described 12 . Following a two--round amplification protocol, biotin labeling and hybridization to Affymetrix 430.2 gene expression arrays, probe level expression values were extracted using RMA 17 and analysis performed using the dChip software 18 following filtering of probes with a lower expression than 100 in either experimental group. To identify differentially expressed genes with age ( Figure  1A ), genes with a >1.5--fold difference in expression with a confidence interval of >90% were extracted. The microarray data used in this study can be found in the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) under accession numbers GSE44923 and GSE27686 (steady--state HSCs), GSE44923 (transplanted HSCs), GSE44923 (YoungBiPS, AgedBiPS and ES cells), GSE6503 (comparative dataset 1), GSE4332 (comparative dataset 2).
qPCR Primers used for SYBR Green mRNA expression analysis
qPCR Primers used for genomic DNA analysis
Universal forward primer (viral backbone):
Telomeric repeats:
Statistical analysis
Genome--wide gene expression microarray data were analyzed using dChip and GSEA, according to manufacturer's instructions. For fold--over--odds calculations, we applied a binomial probability calculation (Poisson distribution approximation).
Otherwise, significance values were calculated by Student's two--tailed t--test.
RESULTS
Genome--wide expression profiling reveals that an aging hematopoietic stem cell signature is maintained following transplantation
It is well established that aging imposes several functional shortcomings on HSCs, including pronounced shifts in the types of mature effector cells produced and alterations in self--renewal 19 . Most existing data argue that these features are autonomous to HSCs since arising phenotypes are visualized when transplanting aged HSCs into young hosts, but not vice versa 4 . However, one concern with HSC transplantation experiments is that they tend to evaluate HSC function based on retrospective analysis of the produced progeny rather than directly at the level of HSCs. To begin to approach this issue, we transplanted young lethally irradiated mice with stem and progenitor cell--enriched bone marrow cells from young and old donors. 4 months post--transplant, we isolated highly purified linage negative, Sca--1+, ckit+, CD48--and CD150+ HSCs from these reconstituted animals, and performed genome--wide expression analyses using Affymetrix 430.2 microarrays ("Transplanted HSCs"; 2 biological arrays/condition). We reasoned that this strategy would provide a mean to expose relatively permanent intrinsic gene expression changes, separate from those that associate strictly with cell division, as transplantation enforces vigorous cell cycling of the otherwise quiescent HSCs 20 . By stringent analysis criteria, these experiments revealed differential expression of 573 probe sets (332 with lower and 241 with higher expression in HSCs derived from aged donors; Table S1 ). Next, we conducted similar analyses on HSCs from young and aged "steady--state" donors (6 biological replicates for each condition). These experiments revealed 490 probe sets with differential expression in the steady--state situation (Table S1) , with the majority being upregulated in aged HSCs (342 probe sets). The gene lists obtained from our two lines of experiments were next intersected to investigate a potential overlap. This revealed a highly significant correlation for both the "Young--associated" (Figure 1A , odds--ratio: 5.1; p=0.000002) and "Aging--associated" (Figure 1B , odds--ratio: 10.7; p<0.000001) probe sets. In an alternative analysis, we implemented Gene Set Enrichment Analysis (GSEA) 21 . This independent approach confirmed a highly significant association of the steady--state young and aged HSC profiles to those obtained from young and aged HSCs subjected to transplantation (p<0.001 for both up--and down--regulated genes, Figure S1 ). A large proportion of these stably differentially expressed genes were also differentially expressed in two independently generated datasets 4,5 of steady--state young and aged HSCs ( Figure S2 ). These data establish that a core set of transcriptional alterations associate with HSC aging. These, in turn, persist through the multiple rounds of cell divisions that associate with HSC transplantation, and can therefore be regarded as relatively stable.
Establishment of iPS lines from young and aged hematopoietic progenitor cells
To generate iPS cells from hematopoietic progenitor cells, Lin--c--Kit+CD45.1+ HSPCs from young or aged mice were isolated and infected for two consecutive days with retroviruses carrying GFP, Oct3/4, Klf4, c--Myc and Sox2. Thereafter, the cells were transferred to embryonic stem (ES) cell culture conditions. After 4--7 days of culture, we began to observe a vast growth of cells, with the emergence of ES--like colonies from day 14 and onwards. However, the vigorous proliferation of other cells persisted in these cultures, complicating the isolation of emerging iPS colonies. To circumvent this problem, we isolated candidate iPS cells from other cells by FACS using antibodies against EpCAM (CD326) 22 and SSEA--1 (Figure 2A ). This strategy enabled effective removal of other proliferating non--iPS cells ( Figure 2B and data not shown). Two iPS lines derived from young HSPCs (Young Blood induced Pluripotent Stem cells; "Young BiPS") and two lines derived from aged HSPCs ("Aged BiPS") were selected for further experimentation.
In initial analyses, we confirmed expression of pluripotency factors and induction of Nanog expression by qRT--PCR in the newly generated iPS lines from both young and old mice ( Figure  2C ). To obtain a wider view of their transcriptional signatures, we performed gene expression analyses of established iPS lines using microarrays. For comparative purposes, we also included samples from three different C57BL/6 ES cell lines. Regardless of young or aged origin, these analyses revealed highly similar expression patterns of BiPS cells to ES cells ( Figure 2D ). By contrast, and as expected, large differences in expression patterns was observed when comparing iPS or ES cell lines to HSCs ( Figure 2D ).
To functionally characterize the generated iPS lines, we first investigated their potential to produce contracting cardiomyocytes in vitro (Movie S1). These experiments verified their potential to produce cells of an alternative lineage, but of the same germ layer (mesoderm) as the original somatic donor cells. To further investigate their lineage potential, we performed a series of blastocyst injections (Table S2) . First, to investigate the potential of BiPS cells to produce a cell lineage with an alternative (ectodermal) germ layer origin than the starting blood cells, we investigated neurons in the hippocampus using Y--chromosome detection in brain sections from a female mouse chimeric with male aged BiPS cells. These analyses confirmed the presence of robust chimeric contribution to the neural lineage ( Figure   2E ). Finally, we set up breeding with a male aged BiPS chimeric male with a wild--type C57BL/6 female, and screened two litters of offspring for germline transmission. Of 17 pups screened, we obtained one mouse with its blood system composing entirely of F1 CD45.1 x CD45.2 cells ( Figure  2F ), with CD45.1 representing a marker of BiPS cells (see below), thereby establishing totipotency of the generated BiPS cells.
Telomere length maintenance of steady state aged and aged BiPS--derived hematopoietic stem cells
Somatic stem cell pools, including HSCs, are needed for the lifetime of an organism 19 .
However, increasing numbers of cell divisions could potentially lead to shortening of telomeres, a mechanism previously proposed to regulate stem cell behavior 23 . We reasoned that this aspect could be particularly relevant in the context of our aged BiPS cells, given their proliferative history both as a consequence of their chronological age and because of the substantial proliferation induced in these cells upon the iPS induction and maintenance. To approach this issue, we examined the telomere length in individual steady--state young (n = 251) and aged (n =246) HSCs.
These data established that aged HSCs harbored approximately 11% shorter telomeres in comparison to their young counterparts (p<0.0234, Figure 3A ), which represents the baseline effect of aging on the telomere length of HSCs.
Although a few previous studies have reported a significant elongation of telomeres in established iPS cell lines compared to the telomere length of the somatic donor cell type 24, 25 , it has remained unclear whether telomere length is appropriately maintained following re--differentiation of iPS cells. Furthermore, it remained a formal possibility that the somatic cell type itself might influence on the telomere length dynamics associated with iPS formation and maintenance. This was relevant to our work, as we used hematopoietic cells, while most previous studies on iPS cells have used fibroblasts as somatic donor cells. When investigating aged BiPS derived HSCs in the primary chimeric setting (which due to cell availability was restricted to the aged BiPS2 clone), we found a striking (2--fold, p<0.0001) elongation of telomeres compared to the blastocyst control HSCs ( Figure 3B ). Next, we conducted similar experiments on aged BiPS--derived HSCs following transplantation.
These experiments demonstrated that aged BiPS maintained their approximately 2-fold elongated telomeres (p<0.0001 for both Aged BiPS1 and Aged BiPS2), despite the exposure of these cells to severe hematopoietic stress/proliferation ( Figure  3C ).
Finally, we investigated the telomere length of HSCs derived from a germline offspring mouse (see Figure 2F ). From this mouse, we could observe a significant reduction in telomere length as compared to the telomere length of HSCs from the primary chimera (parent), although telomere length still remained significantly longer in such offspring (approximately 31% longer compared to that of the somatic starting cells, p<0.0001) ( Figure 3D ). Taken together, these experiments demonstrate that iPS formation from HSPCs associates with elongation of telomeres in a similar manner as previously described for iPS cells with a fibroblast origin 24 .
Reprogramming of aged hematopoietic progenitors into totipotency alleviates the functional alterations that associate with chronological hematopoietic aging
As a last and main aim of our work, we set out to functionally characterize the hematopoietic differentiation capacity of BiPS from aged HSPCs. Despite extensive research, the exact cues guiding in vitro differentiation of ES/iPS cells into adult--type
HSCs have not yet been established. Therefore, we evaluated the hematopoietic differentiation potential of young BiPS and aged BiPS cells in chimeric mice generated via blastocyst injections (Table  S2 ). Because we had a specific interest in the hematopoietic system, we had initially devised our experiments such that we could evaluate the BiPS derived contribution using the congenic CD45.1 (expressed on BiPS cells) and CD45.2 (blastocyst derived cells) markers. As CD45 is expressed on all nucleated blood cells, this made it possible to detail hematopoiesis derived from young BiPS and aged BiPS in chimeric mice in a direct manner. As lineage skewing is a dominant feature of HSC aging, we first evaluated the lineage distribution of BiPS derived cells in the primary chimeric mice 26--29 . These analyses revealed that the hematopoietic lineage distributions of iPS--derived cells, regardless of origin, were remarkably similar to those of the endogenous blastocyst origin ( Figure  4A ). Another hallmark of HSC aging is a dramatic increase in numbers of phenotypically defined HSCs 4,5,27,28 . We therefore evaluated this aspect in mice chimeric with aged BiPS cells, but failed to observe any differences when comparing to the blastocyst--derived HSCs ( Figure 4B ). By contrast, and in agreement with previous data 4, 5, 27, 28 , aged steady--state mice displayed dramatically elevated frequencies of HSCs (12.9--fold, p<0.0001; Figure 4B ).
Next, we explored the capacity of aged BiPS cells to regenerate a hematopoietic system in a competitive transfer setting. To this end, we transplanted BM mononuclear cells from primary aged BiPS chimeric mice into lethally irradiated CD45.2 recipient hosts (2--5 x 10 6 cells/mouse). 16 weeks after transplantation, we evaluated the aged BiPS and blastocyst derived hematopoiesis in the peripheral blood of these hosts. These experiments revealed the aged BiPS reconstitution to be of similar magnitude and quality when compared to the reconstitution patterns obtained from young HSCs in steady state ( Figure 4C and 4D) , as well as to the reconstitution pattern observed from the blastocyst control ( Figure  4D ). This was in sharp contrast to chronologically aged HSCs, which were characterized by a dramatic reduction in repopulation capacity (23.8--fold, p<0.0001) ( Figure 4C ). Finally, we performed more detailed investigations to explore the intrinsic ability of aged BiPS--derived HSCs to generate naïve T cells. We were particularly interested in this aspect as this parameter is normally difficult to probe in steady--state aged mice due to the thymic atrophy that accompanies aging. To this end, we estimated the frequencies of T cells containing T--cell receptor excision circles (TRECs), a molecular marker of recent thymic emigrants 13 , per transplanted HSC. These analyses revealed that steady--state aged HSCs have a strongly reduced T cell potential when compared to their young counterparts (38.4--fold reduction, p=0.005, Figure 4E ). By contrast, aged
BiPS derived HSCs generated naïve T cells at similar levels as both young HSCs and the endogenous blastocyst control--derived HSCs ( Figure 4E ).
ISCUSSION
Many parameters act together and complicate both the study and generalizations
that can be made about the aging of multicellular organisms. These include not only the highly varying onset in both time and degree whereby aging affects different organs and tissues, but also its pleiotropic outcomes. Such considerations aside, one common feature of aging involves what seems as an inevitable loss of overall fitness.
At a cellular level, this could result in either the generation of functionally defective cells, a reduced ability in the generation of appropriate cells, or a combination of both scenarios. The recognition that most organs and tissues are maintained by primitive self--renewing stem cells, whose sole function is to provide organisms with appropriate cellular offspring for a lifetime, has in recent years fuelled the emergence of theories of stem cell origins to the aging process 3, 19 . The blood system is particularly amenable to study the autonomous aspects of these processes because of its extensively well--established character and the ability to regenerate an entire blood system from HSCs via transplantation.
An initial striking observation made in these studies was the dramatic elongation of telomeres that associated with the reprogramming process. These telomeres were appropriately maintained during the transition of iPS cells to differentiated progeny, and required germline dilution for substantial shortening, which agree with recent data showing that the combined telomere lengths of the parents determine telomere lengths of offspring 30 . However, while telomere extension may be a necessity for the generation of functional iPS cells, the long telomeres of C57BL/6 mice 14 combined with the fact that chronologically aged HSCs show only modest telomere shortenings, argue perhaps against telomere attrition as the primary driver of murine HSC aging.
We interpret our results on the "young--like" functional capacity of aged-derived BiPS cells to support a view in which reversible epigenetic (and transcriptional) alterations are central for the development and/or maintenance of the phenotypes associated with HSC aging. While a few reports have previously suggested that iPS cells themselves can associate with varying degrees of molecular "resemblance", or "memory" of its somatic donor origin 31, 32 , we could find little evidence for an epigenetic memory with functional consequences in the BiPS lines studied here. Some data argue that this central question perhaps can be explained from the perspective of an incomplete reprogramming process 33 . In an alternative interpretation, it might be envisioned that the strategy used in our work could favor selection of a subset of HSPCs unaffected by age and/or DNA damage. While we formally cannot rule out this possibility, we however consider it less likely. This is foremost based on the similarities in efficiencies of iPS formation of young and aged HSPCs (unpublished observations), and the very strong dominance of myeloid--biased HSCs in the aging setting 4 . It might also be conceivable that aging HSPCs have acquired mutations that by themselves result in altered epigenetic features. An extension of this view would be that initial causative mutations would be compensated for during the iPS process and thus redundant for subsequent re-differentiation. Our experiments did not address this issue directly, but we did find that young BiPS, aged BiPS and ES cells had remarkably similar genome--wide expression profiles and thus showed no evidence of transcriptional compensation.
Previously, sequencing of murine iPS lines revealed a mutational spectra correlating distinctly to that observed in the somatic cell donor cells 34 aged BiPS lines. Chimeric ratios are depicted as described previously 26, 27 for both blastocyst derived (B) and iPS derived (i) hematopoiesis. Numbers above bars denote individual mice, whose total blood cell chimerism can be found in Table  S2 . correspond to #1--25 in Fig. 4A . 
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